Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis

BACKGROUND: Recently, ocrelizumab (Ocrevus®) was approved for the treatment of primary progressive multiple sclerosis (PPMS) based on data from the ORATORIO clinical trial. Real-world data about the clinical effectiveness of ocrelizumab has yet to be gathered. OBJECTIVE: The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniels, K., van der Nat, P. B., Frequin, S. T. F. M., van der Wees, P. J., Biesma, D. H., Hoogervorst, E. L. J., van de Garde, E. M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313157/
https://www.ncbi.nlm.nih.gov/pubmed/32607256
http://dx.doi.org/10.1155/2020/5463451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313157/
https://www.ncbi.nlm.nih.gov/pubmed/32607256
http://dx.doi.org/10.1155/2020/5463451

Ejemplares similares